MPXEF fully diluted shares on 8/28/2018 Diluted Shares: 638.5mm Revenues – Last Quarter: C$14.5mm (info from AB: https://www.newcannabisventures.com/canadian-bioceutical-corp-bcc-cbicf-investor-dashboard/ P.S.MPXEF is AB's client.